Skip to main content
Clinical Trials/ISRCTN01000893
ISRCTN01000893
Completed
未知

Effect of pregabalin in acute post-operative pain and functional recovery for laparoscopic cholecystectomy

Pfizer (Canada)0 sites162 target enrollmentFebruary 13, 2007

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Pfizer (Canada)
Enrollment
162
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

2010 results in https://doi.org/10.1093/bja/aeq116 (added 26/03/2021)

Registry
who.int
Start Date
February 13, 2007
End Date
June 21, 2008
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Pfizer (Canada)

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients 18 to 65 years of age undergoing cholecystectomy under general anesthesia
  • 2\. Able to tolerate standard medications \- 1000 mg of acetaminophen and 500 mg of naproxen

Exclusion Criteria

  • 1\. Clinically diagnosed acute pancreatitis requiring urgent cholecystectomy
  • 2\. Allergy to gabapentin or pregabalin
  • 3\. Allergy to Non\-Steroidal Anti\-Inflammatory Drugs (NSAID) or acetaminophen
  • 4\. No analgesic within 24 hours before surgery (other than premedication)
  • 5\. Patients with Body Mass Index (BMI) more than 40
  • 6\. Serious organ disease
  • 7\. Creatinine clearance less than or equal to 60 mL
  • 8\. Chronic pain patients requiring more than 30 mg morphine per day or equivalent
  • 9\. Severe psychiatric disease
  • 10\. Drug addiction

Outcomes

Primary Outcomes

Not specified

Similar Trials